Holen Sie sich die Stockscreener-App
0.1649
3.63%
0.0053
Schlusskurs vom Vortag:
$0.1596
Offen:
$0.156
24-Stunden-Volumen:
946.81K
Relative Volume:
0.47
Marktkapitalisierung:
$2.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.66M
KGV:
-0.0119
EPS:
-13.84
Netto-Cashflow:
$-10.14M
1W Leistung:
+3.12%
1M Leistung:
-16.68%
6M Leistung:
-86.66%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.156
$0.172
1-Wochen-Bereich:
$0.156
$0.1848
52-Wochen-Spanne:
$0.1509
$2.16
Tnf Pharmaceuticals Inc Stock (TNFA) Company Profile
Firmenname
Tnf Pharmaceuticals Inc
Sektor
Branche
Telefon
856-848-8698
Adresse
1185 AVENUE OF THE AMERICAS, NEW YORK
Vergleichen Sie TNFA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNFA
Tnf Pharmaceuticals Inc
|
0.1651 | 2.35M | 0 | -23.66M | -10.14M | -13.84 |
|
ONC
Beone Medicines Ltd Adr
|
257.06 | 26.69B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.94 | 114.81B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.2213 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
83.53 | 6.60B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
494.77 | 65.36B | 14.09B | 4.50B | 2.96B | 39.28 |
Tnf Pharmaceuticals Inc Aktie (TNFA) Neueste Nachrichten
Analyzing TNF Pharmaceuticals (NASDAQ:TNFA) & Aspira Women’s Health (NASDAQ:AWH) - Defense World
Sarcopenia Pipeline Drugs Market 2034: EMA, PDMA, FDA - openPR.com
Sarcopenia Market Growth to Accelerate in Forecast Period - openPR.com
Pre-market Movers: CMRX, CPIX, PBM, CRVO... - RTTNews
Wells Fargo & Company Has Lowered Expectations for Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price - Defense World
TNF Pharmaceuticals amends bylaws to change voting requirements By Investing.com - Investing.com Nigeria
TNF Pharmaceuticals amends bylaws to change voting requirements - Investing.com
TNF Pharmaceuticals Amends Bylaws to Alter Voting Rules - TipRanks
TNF Pharmaceuticals announces promising study results By Investing.com - Investing.com Nigeria
TNF Pharmaceuticals announces promising study results - Investing.com Australia
TNF Pharmaceuticals and Renova Health Report Positive Results in Identifying Targets for Treating TNF-Driven Inflammation in Patients Receiving GLP-1 Agonists - Business Wire
A new trading data show TNF Pharmaceuticals Inc (TNFA) is showing positive returns. - Sete News
Let’s Jump Into The Magnite Inc (NASDAQ: MGNI) Stock Forecast - Marketing Sentinel
TNF Pharmaceuticals Inc Inc. (TNFA) Price Performance: A Guide to Financial Ratios - investchronicle.com
Is TNF Pharmaceuticals Inc (TNFA) worth investing in despite its overvalued state? - uspostnews.com
Gaining Ground: TNF Pharmaceuticals Inc (TNFA) Closes Lower at 0.25, Down -9.00 - DWinneX
Comparing TNF Pharmaceuticals (NASDAQ:TNFA) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World
TNF Pharmaceuticals Inc (NASDAQ:TNFA) Is Looking Good Over The Long Term, Dropped Nearly -46.01% Over A Month. – Marketing Sentinel - Marketing Sentinel
Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ - GlobeNewswire
Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.
TNF Pharmaceuticals Inc (TNFA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Sete News
TNF Pharmaceuticals To Use AI To Recruit Patients For Drug Development: Retail Stays Bearish - MSN
TNF and Renova Health use AI to identify patients for GLP-1 treatments - Yahoo Finance
TNF Pharmaceuticals To Use AI To Recruit Patients For Drug Development: Retail Stays Bearish By Stocktwits - Investing.com India
TNF Pharmaceuticals uses AI to refine patient selection for trials By Investing.com - Investing.com South Africa
TNF Pharmaceuticals uses AI to refine patient selection for trials - Investing.com
TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug Development - Business Wire
Clearmind Medicine Inc Inc. (CMND) Price Performance and Its Relation to the Tech Industry - investchronicle.com
TNF Pharmaceuticals Inc Inc. (TNFA) Price Performance Over the Years: A Comparative Study - investchronicle.com
Market Recap Check: Sangamo Therapeutics Inc (SGMO)’s Positive Finish at 0.71, Up/Down 2.96 - DWinneX
Gaining Ground: TNF Pharmaceuticals Inc (TNFA) Closes Lower at 0.18, Down -25.44 - DWinneX
Pre-market Movers: OPTN, WINT, AKBA, GCTK... - RTTNews
Pre-market Movers: CHRO, QURE, FOTA, LLY... - RTTNews
Why Liberty Energy Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket - Benzinga
TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society’s Spring Meeting 2025 - The Joplin Globe
Zijin Mining Group Company Limited (OTCMKTS:ZIJMY) Sees Large Drop in Short Interest - Defense World
Eli Lilly and Company (NYSE:LLY) Given New $928.00 Price Target at Guggenheim - Defense World
TNF Pharmaceuticals, Inc. SEC 10-K Report - TradingView
TNF Pharmaceuticals Inc: Navigating Market Fluctuations with a 0.75M Market Cap - investchronicle.com
TNFA stock touches 52-week low at $0.32 amid market challenges - Investing.com Canada
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Now Is A Good Time To Buy TNF Pharmaceuticals Inc (NASDAQ: TNFA) - Marketing Sentinel
A Key Driver Transforming the TNF Alpha Inhibitors Market in 2025: The Prevalence Of Inflammatory Diseases ... - WhaTech
Contrasting Myriad Genetics (NASDAQ:MYGN) & TNF Pharmaceuticals (NASDAQ:TNFA) - Defense World
TNF Pharmaceuticals faces Nasdaq delisting over price - Investing.com
TNF Pharmaceuticals faces Nasdaq delisting over price By Investing.com - Investing.com India
Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Issuance of Key Patent - Business Wire
Finanzdaten der Tnf Pharmaceuticals Inc-Aktie (TNFA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.30%
3.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):